Advisor Group Holdings, Inc. Caladrius Biosciences, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	BUY	$0.63 - $1.03 $15 - $25	25 Added 0.47%	5,306 $4,000
Q3 2021 Nov 05, 2021	SELL	$1.15 - $1.57 $11 - $15	-10 Reduced 0.19%	5,281 $6,000
Q1 2021 May 13, 2021	BUY	$1.44 - $2.89 $14 - $28	10 Added 0.19%	5,291 $10,000
Q4 2020 Feb 10, 2021	SELL	$1.39 - $1.87 $4,851 - $6,526	-3,490 Reduced 39.79%	5,281 $7,000
Q1 2020 May 18, 2020	BUY	$1.21 - $3.47 $10,612 - $30,435	8,771 New	8,771 $16,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.